  See all
 |
Articles: Gynecologic Oncology |
Prior Articles
Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma
Virchows Archiv, 09/09/09
Locally advanced cervical cancer associated with complete uterine prolapse
European Journal of Cancer Care, 09/09/09 Loss of programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
Molecular Cancer, 09/08/09
Free full text
The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women
International Journal of Cancer, 09/08/09 Primary fallopian tube carcinoma: Results of a retrospective analysis of 64 patients
Gynecologic Oncology, 09/08/09 Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer
Gynecologic Oncology, 09/08/09 mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
Clinical Cancer Research, 09/08/09 Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome
Gynecologic Oncology, 09/08/09 Brain metastasis as a late manifestation of ovarian carcinoma
European Journal of Cancer Care, 09/08/09 Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
Journal of Clinical Oncology, 09/04/09 A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172
Gynecologic Oncology, 09/04/09 Natural history of persistent high-risk human papillomavirus infections in Korean women
Gynecologic Oncology, 09/04/09 Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
The Lancet Oncology - Online First, 09/03/09 Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members
Journal of Clinical Oncology, 09/03/09 RNA splicing factors regulated by HPV16 during cervical tumour progression
The Journal of Pathology, 09/03/09 Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules
Journal of Clinical Oncology, 09/02/09 Conformal Brachytherapy Planning for Cervical Cancer Using Transabdominal Ultrasound
International Journal of Radiation Oncology*Biology*Physics, 09/02/09 The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: Preliminary results
Gynecologic Oncology, 09/02/09 Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review
Gynecologic Oncology, 09/02/09
Revew Article
Topical treatment of CIN 2+ by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study
Gynecologic Oncology, 09/02/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
